• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未完全封闭的HIV-1包膜糖蛋白可抵御广泛中和抗体,同时介导高效的HIV-1进入。

Incompletely closed HIV-1 envelope glycoproteins resist broadly neutralizing antibodies while mediating efficient HIV-1 entry.

作者信息

Parthasarathy Durgadevi, Pickthorn Stephanie, Ahmed Shamim, Mazurov Dmitry, Jeffy Jeffy, Shukla Rajni Kant, Sharma Amit, Herschhorn Alon

机构信息

Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, 55455, USA.

Department of Veterinary Biosciences, Department of Microbial Infection & Immunity, The Ohio State University, Columbus, OH, 43210, USA.

出版信息

Npj Viruses. 2025 Jan 15;3(1):3. doi: 10.1038/s44298-024-00082-w.

DOI:10.1038/s44298-024-00082-w
PMID:40295863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11735869/
Abstract

HIV-1 envelope glycoproteins (Envs) mediate viral entry and are sole target of neutralizing antibodies. Thus, HIV-1 Envs must maintain a delicate balance between evading neutralizing antibodies while still preserving viral compatibility to mediate entry into target cells. Here, we studied the viral entry effeciency, fitness, and replication of an incompletely closed, transmitted/founder HIV-1 Envs (CH040), which are highly resistant to most bnAbs. CH040 Envs mediated HIV-1 entry to target cells as efficient as other primary Envs, suggesting that antibody resistance and efficient viral entry can develop independently. Expression of CH040 Envs was comparable to other Envs and most CH040 variants that were rationally engineered to increase bnAb resistance showed no significant decrease in their ability to mediate HIV-1 entry. We detected robust in vitro spread of SHIV CH040 in pig-tailed macaque lymphocytes that was comparable to efficient spread of other SHIVs. Our study provides insights into the relationship between bnAb resistance and efficient HIV-1 entry.

摘要

HIV-1包膜糖蛋白(Env)介导病毒进入,是中和抗体的唯一靶点。因此,HIV-1 Env必须在逃避中和抗体与保持病毒与靶细胞结合能力之间保持微妙平衡。在此,我们研究了一种不完全封闭的、传播/奠基型HIV-1 Env(CH040)的病毒进入效率、适应性和复制情况,该Env对大多数bnAb具有高度抗性。CH040 Env介导HIV-1进入靶细胞的效率与其他原始Env相当,这表明抗体抗性和高效的病毒进入可以独立发展。CH040 Env的表达与其他Env相当,大多数经过合理改造以增加bnAb抗性的CH040变体在介导HIV-1进入的能力上没有显著下降。我们检测到SHIV CH040在食蟹猴淋巴细胞中具有强劲的体外传播能力,与其他SHIV的高效传播相当。我们的研究为bnAb抗性与高效HIV-1进入之间的关系提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11735869/8a71e3787a16/44298_2024_82_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11735869/373973a2b1de/44298_2024_82_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11735869/70251fe90432/44298_2024_82_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11735869/dbc574275421/44298_2024_82_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11735869/353241cb661c/44298_2024_82_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11735869/b8b5e2363bbe/44298_2024_82_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11735869/8a71e3787a16/44298_2024_82_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11735869/373973a2b1de/44298_2024_82_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11735869/70251fe90432/44298_2024_82_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11735869/dbc574275421/44298_2024_82_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11735869/353241cb661c/44298_2024_82_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11735869/b8b5e2363bbe/44298_2024_82_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56de/11735869/8a71e3787a16/44298_2024_82_Fig6_HTML.jpg

相似文献

1
Incompletely closed HIV-1 envelope glycoproteins resist broadly neutralizing antibodies while mediating efficient HIV-1 entry.未完全封闭的HIV-1包膜糖蛋白可抵御广泛中和抗体,同时介导高效的HIV-1进入。
Npj Viruses. 2025 Jan 15;3(1):3. doi: 10.1038/s44298-024-00082-w.
2
Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted / founder sensitivity to broadly neutralizing antibodies.HIV-1包膜糖蛋白的构象灵活性调节了传播/奠基者病毒对广泛中和抗体的敏感性。
bioRxiv. 2023 Dec 5:2023.09.13.557082. doi: 10.1101/2023.09.13.557082.
3
Conformation of HIV-1 Envelope Governs Rhesus CD4 Usage and Simian-Human Immunodeficiency Virus Replication.HIV-1 包膜构象决定恒河猴 CD4 使用和猿猴-人免疫缺陷病毒复制。
mBio. 2022 Feb 22;13(1):e0275221. doi: 10.1128/mbio.02752-21. Epub 2022 Jan 11.
4
Alternative substitutions of N332 in HIV-1 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan.HIV-1 gp120 中的 N332 替代物会对包膜糖蛋白的功能产生不同影响,也会影响病毒对靶向 V3 聚糖的广泛中和抗体的敏感性。
mBio. 2024 Apr 10;15(4):e0268623. doi: 10.1128/mbio.02686-23. Epub 2024 Mar 12.
5
Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies.不同的HIV-1进入表型与传播、亚型特异性以及对广泛中和抗体的抗性相关。
Retrovirology. 2014 Jun 23;11:48. doi: 10.1186/1742-4690-11-48.
6
Conformations of Human Immunodeficiency Virus Envelope Glycoproteins in Detergents and Styrene-Maleic Acid Lipid Particles.人免疫缺陷病毒包膜糖蛋白在去污剂和苯乙烯-马来酸脂类脂质颗粒中的构象。
J Virol. 2023 Jun 29;97(6):e0032723. doi: 10.1128/jvi.00327-23. Epub 2023 May 31.
7
Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies.HIV-1 包膜糖蛋白的构象灵活性调节了传播/原始病毒对广泛中和抗体的敏感性。
Nat Commun. 2024 Aug 26;15(1):7334. doi: 10.1038/s41467-024-51656-4.
8
Inhibition of human immunodeficiency virus (HIV-1) infectivity by expression of poorly or broadly neutralizing antibodies against Env in virus-producing cells.在产生病毒的细胞中表达针对 Env 的中和活性弱或广谱中和抗体抑制人类免疫缺陷病毒(HIV-1)感染。
J Virol. 2024 Feb 20;98(2):e0159423. doi: 10.1128/jvi.01594-23. Epub 2024 Jan 30.
9
Changes in the V1 Loop of HIV-1 Envelope Glycoproteins Can Allosterically Modulate the Trimer Association Domain and Reduce PGT145 Sensitivity.HIV-1 包膜糖蛋白 V1 环的变化可以变构调节三聚体缔合结构域并降低 PGT145 的敏感性。
ACS Infect Dis. 2021 Jun 11;7(6):1558-1568. doi: 10.1021/acsinfecdis.0c00899. Epub 2021 May 18.
10
Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.多种重组HIV-1包膜蛋白无法激活表达广泛中和抗HIV-1抗体PG9和447-52D的种系B细胞受体的B细胞。
J Virol. 2014 Mar;88(5):2645-57. doi: 10.1128/JVI.03228-13. Epub 2013 Dec 18.

本文引用的文献

1
Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies.HIV-1 包膜糖蛋白的构象灵活性调节了传播/原始病毒对广泛中和抗体的敏感性。
Nat Commun. 2024 Aug 26;15(1):7334. doi: 10.1038/s41467-024-51656-4.
2
mRNA-based HIV-1 vaccines.基于信使 RNA 的 HIV-1 疫苗。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0004124. doi: 10.1128/cmr.00041-24. Epub 2024 Jul 17.
3
Insights from HIV-1 vaccine and passive immunization efficacy trials.从 HIV-1 疫苗和被动免疫效力试验中获得的见解。
Trends Mol Med. 2024 Oct;30(10):908-912. doi: 10.1016/j.molmed.2024.05.017. Epub 2024 Jun 18.
4
Alternative substitutions of N332 in HIV-1 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan.HIV-1 gp120 中的 N332 替代物会对包膜糖蛋白的功能产生不同影响,也会影响病毒对靶向 V3 聚糖的广泛中和抗体的敏感性。
mBio. 2024 Apr 10;15(4):e0268623. doi: 10.1128/mbio.02686-23. Epub 2024 Mar 12.
5
HIResist: a database of HIV-1 resistance to broadly neutralizing antibodies.HIResist:一个 HIV-1 对广泛中和抗体的耐药性数据库。
Bioinformatics. 2024 Mar 4;40(3). doi: 10.1093/bioinformatics/btae103.
6
Ultrasensitive quantification of HIV-1 cell-to-cell transmission in primary human CD4 T cells measures viral sensitivity to broadly neutralizing antibodies.超敏检测原发性人 CD4 T 细胞中 HIV-1 细胞间传播可衡量病毒对广泛中和抗体的敏感性。
mBio. 2024 Jan 16;15(1):e0242823. doi: 10.1128/mbio.02428-23. Epub 2023 Dec 8.
7
Enhancing anti-viral neutralization response to immunization with HIV-1 envelope glycoprotein immunogens.增强对HIV-1包膜糖蛋白免疫原免疫接种的抗病毒中和反应。
NPJ Vaccines. 2023 Nov 24;8(1):181. doi: 10.1038/s41541-023-00774-z.
8
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses.首例人体种系靶向 HIV 纳米颗粒疫苗诱导广泛且针对公众的辅助性 T 细胞反应。
Sci Transl Med. 2023 May 24;15(697):eadf3309. doi: 10.1126/scitranslmed.adf3309.
9
Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies .HIV-1逃避广泛中和抗体的间接机制
ACS Infect Dis. 2023 Jan 13;9(1):5-8. doi: 10.1021/acsinfecdis.2c00573. Epub 2022 Dec 13.
10
Conformation of HIV-1 Envelope Governs Rhesus CD4 Usage and Simian-Human Immunodeficiency Virus Replication.HIV-1 包膜构象决定恒河猴 CD4 使用和猿猴-人免疫缺陷病毒复制。
mBio. 2022 Feb 22;13(1):e0275221. doi: 10.1128/mbio.02752-21. Epub 2022 Jan 11.